Florian Emmerich

5.9k total citations · 1 hit paper
59 papers, 2.7k citations indexed

About

Florian Emmerich is a scholar working on Immunology, Hepatology and Cancer Research. According to data from OpenAlex, Florian Emmerich has authored 59 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Immunology, 8 papers in Hepatology and 7 papers in Cancer Research. Recurrent topics in Florian Emmerich's work include Immune Cell Function and Interaction (32 papers), T-cell and B-cell Immunology (30 papers) and Immunotherapy and Immune Responses (21 papers). Florian Emmerich is often cited by papers focused on Immune Cell Function and Interaction (32 papers), T-cell and B-cell Immunology (30 papers) and Immunotherapy and Immune Responses (21 papers). Florian Emmerich collaborates with scholars based in Germany, United Kingdom and United States. Florian Emmerich's co-authors include Claus Scheidereit, Daniel Krappmann, Bernd Dörken, Kurt Bommert, Hans‐Dieter Royer, Markus Y. Mapara, W Arnold, Edgar Grinstein, Andreas Greiner and Ralf C. Bargou and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Florian Emmerich

50 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

1997 638 citations Florian Emmerich, Kurt Bommert et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Florian Emmerich

Since Specialization

Citations

This map shows the geographic impact of Florian Emmerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Emmerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Emmerich more than expected).

Fields of papers citing papers by Florian Emmerich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florian Emmerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Emmerich. The network helps show where Florian Emmerich may publish in the future.

Co-authorship network of co-authors of Florian Emmerich

This figure shows the co-authorship network connecting the top 25 collaborators of Florian Emmerich. A scholar is included among the top collaborators of Florian Emmerich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florian Emmerich. Florian Emmerich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The New HLA ‐ DRB1 11:343 Allele Encoding for A Distinctive Peptide‐Binding Domain 2025 ·HLA* ·(unknown), (unknown), Murielle Verboom, Michael Hallensleben, Florian Emmerich	0
2	Limited vaccine-induced CD8+ T cell immunity in HIV-infected immunological nonresponders 2025 ·JCI Insight ·(unknown), (unknown), (unknown), (unknown), Florian Emmerich, (unknown), Siegbert Rieg, Susanne Usadel, Bertram Bengsch, Tobias Boettler, Hendrik Luxenburger, Christoph Neumann‐Haefelin, Matthias C. Müller, Robert Thimme, Maike Hofmann	0
3	HLA‐C15:02:01:69Q, A New Allele With A Different Splice Site 2025 ·HLA* ·(unknown), (unknown), Murielle Verboom, Michael Hallensleben, Florian Emmerich	1
4	The Novel HLA ‐B38:123 Allele With A Unique M‐Leader Sequence 2025 ·HLA* ·(unknown), (unknown), Murielle Verboom, Michael Hallensleben, Florian Emmerich	0
5	HLA‐C14:171* , a New Allele With a Rare Extracellular α3 Domain 2025 ·HLA ·(unknown), (unknown), Murielle Verboom, Michael Hallensleben, Florian Emmerich	0
6	Attenuated effector T cells are linked to control of chronic HBV infection 2024 ·Nature Immunology ·Kathrin Heim, Sagar Sagar, Özlem Soğukpınar, Sian Llewellyn‐Lacey, David A. Price, Florian Emmerich, Anke Kraft, Markus Cornberg, (unknown), Percy A. Knolle, Dirk Wohlleber, Bertram Bengsch, Tobias Boettler, Christoph Neumann‐Haefelin, Robert Thimme, Maike Hofmann	24
7	A novel HLA‐DPB1 allele, HLA‐DPB11447:01, identified by next‐generation sequencing 2023 ·HLA* ·Mirzokhid Rakhmanov, (unknown), Murielle Verboom, Florian Emmerich	1
8	Next generation sequencing reveals a novel HLA‐C allele, HLA‐C16:201* 2023 ·HLA ·Mirzokhid Rakhmanov, Murielle Verboom, (unknown), Florian Emmerich	1
9	Circulating multimeric immune complexes contribute to immunopathology in COVID-19 2022 ·Nature Communications ·Jakob Ankerhold, Sebastian Giese, Philipp Kolb, Andrea Maul‐Pavicic, Reinhard Voll, (unknown), Kevin Ciminski, Clemens Kreutz, Achim Lother, Ulrich Salzer, Wolfgang Bildl, Tim Welsink, Nils G. Morgenthaler, Andrea Busse Grawitz, Florian Emmerich, Daniel Steinmann, Daniela Huzly, Martin Schwemmle, Hartmut Hengel, Valeria Falcone	23
10	Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection 2022 ·Journal of Hepatology ·Janine Kemming, (unknown), Marcus Panning, Daniela Huzly, Jiabin Huang, Marc Lütgehetmann, Sven Pischke, Julian Schulze zur Wiesch, Florian Emmerich, Sian Llewellyn‐Lacey, David A. Price, Yakup Tanriver, Klaus Warnatz, Tobias Boettler, Robert Thimme, Maike Hofmann, Nicole Fischer, Christoph Neumann‐Haefelin	17
11	TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection 2020 ·Gut ·Kathrin Heim, Benedikt Binder, Sagar Sagar, Dominik Wieland, (unknown), Sian Llewellyn‐Lacey, Emma Gostick, David A. Price, Florian Emmerich, (unknown), Anke Kraft, Markus Cornberg, Tobias Boettler, Christoph Neumann‐Haefelin, Dietmar Zehn, Bertram Bengsch, Maike Hofmann, Robert Thimme	55
12	OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection 2019 ·Journal of Hepatology ·(unknown), Katharina Wild, M Smits, Katharina Zoldan, Benedikt Csernalabics, Tobias Flecken, Julia Lang‐Meli, (unknown), Florian Emmerich, Maike Hofmann, Robert Thimme, Christoph Neumann‐Haefelin, Tobias Boettler	61
13	Follicular T helper cells shape the HCV-specific CD4+ T cell repertoire after virus elimination 2019 ·Journal of Clinical Investigation ·M Smits, Katharina Zoldan, Naveed Ishaque, Zuguang Gu, Katharina Jechow, Dominik Wieland, Christian Conrad, Roland Eils, Catherine Fauvelle, Thomas F. Baumert, Florian Emmerich, Bertram Bengsch, Christoph Neumann‐Haefelin, Maike Hofmann, Robert Thimme, Tobias Boettler	42
14	Genome-wide Profiling in AML Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation 2011 ·Biology of Blood and Marrow Transplantation ·Miguel Waterhouse, Dietmar Pfeifer, Milena Pantić, Florian Emmerich, Hartmut Bertz, Jürgen Finke	34
15	Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis 2010 ·Nephrology Dialysis Transplantation ·Jochen Wilpert, K.-G. Fischer, P. Pisarski, Thorsten Wiech, Michael Daskalakis, Alan D. Ziegler, (unknown), Oliver Drognitz, Florian Emmerich, Gerd Walz, Marcel Geyer	94
16	A novel HLA-C allele, HLA-Cw06:20 2010 ·Tissue Antigens* ·Florian Emmerich, Michael Daskalakis, C. Niemeyer	0
17	A novel HLA-B allele, B14:10, identified by haplotype-specific sequencing 2010 ·Tissue Antigens* ·Florian Emmerich, Michael Daskalakis, Charlotte M. Niemeyer	1
18	Identification of a novel HLA‐DQB1 allele, HLA‐DQB10632 2007 ·Tissue Antigens* ·Florian Emmerich, C. Schönemann, (unknown), Peter A. Horn, A. Salama	4
19	High‐level serum B‐cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura 2006 ·British Journal of Haematology ·Florian Emmerich, (unknown), (unknown), Julian Kamhieh‐Milz, (unknown), Lorena Martinez‐Gamboa, Thomas Dörner, Abdulgabar Salama	93
20	Inactivating I kappa B epsilon mutations in Hodgkin/Reed–Sternberg cells 2003 ·The Journal of Pathology ·Florian Emmerich, Sebastian Theurich, Michael Hummel, (unknown), (unknown), Konstanze Döhner, Kurt Bommert, Harald Stein, Bernd Dörken	105

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact